Entrada Therapeutics
Entrada Therapeutics’ mission is to treat devastating diseases through the intracellular delivery of biologics. Entrada’s technology enables the efficient intracellular delivery of proteins, peptides and nucleic acids, thus allowing for the development of programs across several intracellular target classes. The Company's novel approach addresses current challenges associated with both large and small molecule therapeutics and represents a fundamental advancement in the delivery of molecules into the cytosol. For more information, please visit www.entradatx.com.
Domain
entradatx.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$100.0M
Founded
2015
Tech Stack (14 technologies)
Frequently Asked Questions
What technologies does Entrada Therapeutics use?+
Entrada Therapeutics uses 14 technologies including Google Analytics, Google Tag Manager, jsDelivr.
What industry is Entrada Therapeutics in?+
Entrada Therapeutics operates in the Biotechnology industry.
Where is Entrada Therapeutics based?+
Entrada Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026